As well as enjoying a fortress-like trading position in its industry, ARM Holdings (LSE: ARM) (NASDAQ: ARMH.US) is tapping in to some powerful medium-term growth trends. To me, the most likely direction for the share price next year seems up.
What about the valuation
I always feel duty bound to mention valuation when talking about ARM Holdings. A high valuation is anathema for many, particularly those of us with a value-investing slant. Indeed, I had to brace myself before hitting the buy button on ARM earlier in the year but, so far, nothing bad happened to me as a result of committing my hard earned to the firms growth story. In fact, the longer I hold the shares, the safer my investment begins to feel.
It took me a long time to wake up to ARMs potential as an investment. The firms potential as a business dawned on me long ago, but the always-high valuation scared me off. Thats a shame. My reticence to invest cost me several hundreds of percent in capital gains what a painful missed opportunity.
It took further learning and a shift in investment philosophy to embolden me sufficiently to take the plunge with ARM. It was the writings of Philip A. Fisher that finally set my lights flashing over high-valuation growth opportunities. I dont know why it took me so long to get around to reading his classic tome, Common Stocks and Uncommon Profits; after all, Warren Buffett had been citing Fisher as an influence on his own investing for decades.
From Fisher, we seem to find the origin of Buffetts buy-wonderful-companies-at-fair-prices mantra. To attempt to sum that up, Fisher seems to encourage us to expect a high valuation on a wonderful growth company enjoying a solid trading niche, such as ARM Holdings. We may view the valuation as a mark of quality, and there is no reason for an earnings multiple, such as the P/E rating, to contract, as long as the medium- to long-term growth prospects of the firm dont diminish.
All guns blazing
ARM Holdings forward prospects seem as vibrant as ever. One area of excitement is the Internet-of-Things opportunity, where ARMs solution resides in its Cortex-M Processors. The range of chips goes into smart sensors, embedded connectivity chips, microcontrollers, wearable devices and other Internet-of-Things applications. The firm reckons that around 50% of its signed licences last year involved the Cortex-M. Thats exciting progress, and if we see the market take off as some predict, that area alone could drive ARMs share price higher in the medium term, or even in the shorter term if investors get a sniff of coming success in the air.
However, the Internet of Things isnt the only opportunity ARM pursues. The company holds a well-defended position at the heart of its industry thanks to its licensing and royalty business model that sees ARM technology incorporated into the worlds consumer technology devices such as smart phones and tablets, whatever the end manufacturer. As the sector evolves, so does ARM, which is why the firm sees a healthy pipeline of opportunities, which it expects to underpin strong forward licence revenue and to increase order backlog. ARM cites market data indicating improving semiconductor industry conditions, which it thinks is driving acceleration in royalty revenue growth as we head towards year-end and into 2015.
Theres no sign of attrition in ARMs trading advantage in the semi-conductor space, and every reason to expect further strong progress in the future. Why should the valuation contract and why shouldnt increasing earnings cause the share price to adjust upwards?
What now?
If we want to invest in a proven growth proposition such as ARM Holdings, we must bite the valuation bullet. At todays 932p share price the forward P/E rating runs at about 32 for year to December 2015, with City analysts predicting a 23% earnings uplift that year. I think that valuation can be justified by looking at averages for earnings growth over several years.
If ARMs growth in earnings accelerates in coming years, as I believe it might, the current valuation may start to look less shocking.
Buying growth companies is one way to drive good portfolio performance. To help me find more strong growers, I’m poring over a new exclusive wealth report from the Motley Fool, which highlights seven steps to serious wealth and signposts compelling investment opportunities available now,ripe for your own analysis.
Amongst other gems, this report points to a pharmaceutical play expected to deliver a compound annual growth rate in earnings of 10% over the next five years. There’s also a great example of a company with effective management, consistent returns on capital and predictable sales.
Going for vibrant firms with great prospects can really deliver for us as investors, so why not run your analysis over ARM Holdings and the opportunities indicated in the Motley Fool report now; it’s free and without obligation. Click here
Get FREE Issues of The Motley Fool Collective
Get straightforward advice on whats really happening with the stock markets, direct to your inbox. Help yourself with our FREE email newsletter designed to help you protect and grow your portfolio wealth.
By providing your email address, you consent to receiving further information on our goods and services and those of our business partners. To opt-out of receiving this information click here. All information provided is governed by our Privacy Statement.
Kevin Godboldowns shares in ARM Holdings The Motley Fool UK has recommended ARM Holdings. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.
